1. Home
  2. AXTA vs RGEN Comparison

AXTA vs RGEN Comparison

Compare AXTA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTA
  • RGEN
  • Stock Information
  • Founded
  • AXTA 1910
  • RGEN 1981
  • Country
  • AXTA United States
  • RGEN United States
  • Employees
  • AXTA N/A
  • RGEN N/A
  • Industry
  • AXTA Paints/Coatings
  • RGEN Medical/Dental Instruments
  • Sector
  • AXTA Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • AXTA Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • AXTA 7.2B
  • RGEN 8.0B
  • IPO Year
  • AXTA 2014
  • RGEN N/A
  • Fundamental
  • Price
  • AXTA $30.79
  • RGEN $118.07
  • Analyst Decision
  • AXTA Buy
  • RGEN Buy
  • Analyst Count
  • AXTA 15
  • RGEN 12
  • Target Price
  • AXTA $41.33
  • RGEN $172.67
  • AVG Volume (30 Days)
  • AXTA 2.8M
  • RGEN 791.0K
  • Earning Date
  • AXTA 05-07-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • AXTA N/A
  • RGEN N/A
  • EPS Growth
  • AXTA 83.38
  • RGEN N/A
  • EPS
  • AXTA 2.05
  • RGEN N/A
  • Revenue
  • AXTA $5,244,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • AXTA $2.45
  • RGEN $13.93
  • Revenue Next Year
  • AXTA $3.37
  • RGEN $14.35
  • P/E Ratio
  • AXTA $15.01
  • RGEN N/A
  • Revenue Growth
  • AXTA 0.96
  • RGEN 4.88
  • 52 Week Low
  • AXTA $27.70
  • RGEN $102.97
  • 52 Week High
  • AXTA $41.66
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • AXTA 41.92
  • RGEN 39.80
  • Support Level
  • AXTA $30.66
  • RGEN $120.55
  • Resistance Level
  • AXTA $31.91
  • RGEN $123.71
  • Average True Range (ATR)
  • AXTA 0.63
  • RGEN 4.63
  • MACD
  • AXTA -0.13
  • RGEN -0.58
  • Stochastic Oscillator
  • AXTA 9.95
  • RGEN 7.59

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: